MYDAYIS

Takeda Pharmaceuticals America, Inc.🇺🇸 United States

FDA Page

Effective Date: Apr 30, 2026
Approval ID: 141a7970-3f06-44ea-9ab7-aeece2c085fc
Products: 4 registered
Version: 13

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use MYDAYIS safely and effectively. See full prescribing information for MYDAYIS. MYDAYIS (mixed salts of a single-entity amphetamine product) extended-release capsules, for oral use, CIIInitial U.S. Approval: 2001

Quick Stats

Total Products4

Labelers2

Label Sections24

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.